PKM and cancer: This novel delivery system exploited the DPP's multivalent topology for efficient trans-membrane transport of PKM2 siRNA into DOX-resistant cancer cells, downregulating PKM2 to disrupt glycolysis, thereby starving ABC transporter-mediated drug efflux and reversing chemoresistance.